Costs associated with retinopathy of prematurity: a systematic review and meta-analysis.

ABSTRACT:

Objectives

To review and analyse evidence regarding costs for retinopathy of prematurity (ROP) screening, lifetime costs and resource use among infants born preterm who develop ROP, and how these costs have developed over time in different regions.

Design

Systematic review and meta-analysis DATA SOURCES: PubMed and Scopus from inception to 23 June 2021.

Eligibility criteria for selecting studies

Included studies presented costs for ROP screening and the lifetime costs (including laser treatment and follow-up costs) and resource use among people who develop ROP. Studies not reporting on cost calculation methods or ROP-specific costs were excluded.

Data extraction and synthesis

Two independent reviewers screened for inclusion and extracted data, including items f

SUBMITTER: Gyllensten H 

PROVIDER: S-EPMC9693652 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature